ICPT bagholders on suicide watch Terrible company manipulating their data to sell a toxic drug that doesn't work at ridiculous prices
GALT
>drug works (phase 2 NASH "failure" was an error in trial design [using wrong dosages, making it too short, not distinguishing between compensated and decompensated cirrhosis], as evidenced by the fact that they're moving onto phase 3 in NASH) >is very safe >cheap to manufacture
Joseph Taylor
Am I only one worried about why do these three trade like penny stocks these days
